Kasai, Kikuo
4 papers on CoChat
Most cited papers
- Verified
Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells
Hattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension
Metabolism, Diabetes, and CancerNF-κB Signaling Pathways
Cited by 487
- Verified
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
Ueki, K., Sasako, T., Okazaki, Y., Kato, M., Okahata, S., Katsuyama, H., Haraguchi, M., Morita, A., Ohashi, K., Hara, K., et al. (2017) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 313
- VerifiedRetracted
RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
Hattori, Y., Jojima, T., Tomizawa, A., Satoh, H., Hattori, S., Kasai, K., & Hayashi, T. (2010) · Diabetologia
Nitric Oxide and Endothelin EffectsDiabetes Treatment and Management
Cited by 183
- Verified
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
Jojima, T., Uchida, K., Akimoto, K., Tomotsune, T., Yanagi, K., Iijima, T., Suzuki, K., Kasai, K., & Aso, Y. (2017) · Atherosclerosis
Diabetes Treatment and ManagementAtherosclerosis and Cardiovascular Diseases
Cited by 105
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free